Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphomaGéraldine Mitou(Centre National de la Recherche Scientifique), Sylvie Giuriato(Université Toulouse III - Paul Sabatier)OncotargetAugust 17, 201510.18632/oncotarget.4999Cited by 49SaveCiteExport RISWatch citationsRelated PapersConditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia|Blood|2010|32